Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Pharma Industry Analysis

UpdatedNov 14, 2025
DataAggregated Company Financials
Companies23
  • 7D1.9%
  • 3M-6.2%
  • 1Y5.0%
  • YTDn/a

Over the last 7 days, the Pharma industry has risen 12%, driven by gains from Camurus of 18%. Meanwhile, Infant Bacterial Therapeutics actually underperformed within the industry, shrinking 18% in the last week. Despite this gain, the industry's performance has been flat over the past year. Looking forward, earnings are forecast to grow by 42% annually.

Industry Valuation and Performance

Has the Swedish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 17 Nov 2025SEK 50.4bSEK 5.3b-SEK 481,709,865.0068.6x-104.6x9.5x
Wed, 15 Oct 2025SEK 53.7bSEK 5.1b-SEK 405,183,865.0067.8x-132.6x10.6x
Fri, 12 Sep 2025SEK 58.5bSEK 5.1b-SEK 405,183,865.0079.1x-144.4x11.5x
Sun, 10 Aug 2025SEK 49.2bSEK 5.0b-SEK 45,588,364.0070.9x-1078.1x9.7x
Tue, 08 Jul 2025SEK 55.6bSEK 4.8b-SEK 525,205,364.0075.9x-105.8x11.6x
Thu, 05 Jun 2025SEK 53.0bSEK 4.8b-SEK 580,421,216.1269.1x-91.3x11x
Sat, 03 May 2025SEK 52.0bSEK 4.8b-SEK 940,419,211.3276.7x-55.3x10.9x
Mon, 31 Mar 2025SEK 49.3bSEK 4.7b-SEK 809,206,422.9771x-60.9x10.5x
Wed, 26 Feb 2025SEK 54.3bSEK 4.7b-SEK 762,468,839.7889.1x-71.2x11.6x
Fri, 24 Jan 2025SEK 48.4bSEK 4.4b-SEK 580,886,482.76132.1x-83.3x10.9x
Sun, 22 Dec 2024SEK 50.0bSEK 4.4b-SEK 615,836,627.11124.5x-81.1x11.2x
Tue, 19 Nov 2024SEK 48.4bSEK 4.4b-SEK 629,146,451.06120.6x-77x10.9x
Thu, 17 Oct 2024SEK 52.9bSEK 4.3b-SEK 676,928,614.47140.2x-78.1x12.3x
Sat, 14 Sep 2024SEK 68.1bSEK 5.9b-SEK 1,169,937,604.05180.3x-58.2x11.6x
Mon, 12 Aug 2024SEK 67.4bSEK 5.6b-SEK 993,346,440.2489.8x-67.9x12x
Wed, 10 Jul 2024SEK 69.8bSEK 6.4b-SEK 868,337,744.9283x-80.4x11x
Fri, 07 Jun 2024SEK 60.8bSEK 6.5b-SEK 871,118,223.7975.5x-69.8x9.4x
Sun, 05 May 2024SEK 49.6bSEK 6.3b-SEK 935,306,041.2466.4x-53x7.9x
Tue, 02 Apr 2024SEK 51.2bSEK 6.2b-SEK 1,038,131,674.5277.6x-49.4x8.2x
Thu, 29 Feb 2024SEK 46.9bSEK 6.2b-SEK 1,041,287,814.5680.1x-45x7.5x
Sat, 27 Jan 2024SEK 69.0bSEK 9.5b-SEK 1,182,168,895.0065.4x-58.4x7.3x
Mon, 25 Dec 2023SEK 68.0bSEK 9.4b-SEK 1,184,189,142.0063x-57.4x7.2x
Wed, 22 Nov 2023SEK 59.9bSEK 9.5b-SEK 1,172,189,523.0053.1x-51.1x6.3x
Fri, 20 Oct 2023SEK 50.5bSEK 9.2b-SEK 1,142,990,886.00105x-44.2x5.5x
Sun, 17 Sep 2023SEK 50.6bSEK 9.2b-SEK 1,177,933,411.00137.6x-43x5.5x
Tue, 15 Aug 2023SEK 52.9bSEK 8.9b-SEK 1,410,542,799.0084.4x-37.5x5.9x
Thu, 13 Jul 2023SEK 48.3bSEK 8.4b-SEK 1,693,236,247.0079.8x-28.5x5.8x
Sat, 10 Jun 2023SEK 47.1bSEK 8.4b-SEK 1,706,792,045.0073.7x-27.6x5.6x
Mon, 08 May 2023SEK 49.0bSEK 8.1b-SEK 1,811,993,872.0070.3x-27.1x6x
Wed, 05 Apr 2023SEK 45.6bSEK 8.0b-SEK 1,793,643,110.0091.9x-25.4x5.7x
Fri, 03 Mar 2023SEK 44.7bSEK 8.0b-SEK 1,783,627,923.00229.9x-25.1x5.6x
Sun, 29 Jan 2023SEK 47.9bSEK 7.3b-SEK 1,965,905,838.00286.1x-24.4x6.6x
Tue, 27 Dec 2022SEK 48.4bSEK 7.3b-SEK 1,910,766,059.00276.3x-25.3x6.6x
Thu, 24 Nov 2022SEK 49.4bSEK 7.2b-SEK 1,955,316,814.0048x-25.3x6.9x
Price to Earnings Ratio

-25.3x


Total Market Cap: SEK 49.4bTotal Earnings: -SEK 1,955,316,814.00Total Revenue: SEK 7.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Pharma Industry Price to Earnings3Y Average -68.4x202320242025
Current Industry PE
  • Investors are relatively neutral on the Swedish Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 8.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 9.5% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Comparison

How does Swedish Pharma compare with similar industries?

SE Market-0.075%
Healthcare1.96%
Pharma1.90%
Pharma1.90%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CAMX CamurusSEK 643.503.0%
+SEK 1.1b		17.9%PE49.1x
SECARE SwedencareSEK 34.800.7%
+SEK 40.0m		-22.2%PE88.4x
ERMA Enorama PharmaSEK 2.859.2%
+SEK 17.9m		-27.1%PS18.8x
ONCOZ OncoZengeSEK 6.3720.2%
+SEK 13.5m		-38.4%PS28.9x
FLERIE FlerieSEK 38.850.4%
+SEK 11.6m		-13.9%PS1203.7x

Latest News

ALZCUR
SEK 2.01
AlzeCure Pharma
7D
3.3%
1Y
73.3%
KDEV
SEK 0.79
Karolinska Development
7D
-6.5%
1Y
-29.5%
MOB
SEK 9.06
Moberg Pharma
7D
-10.1%
1Y
-48.2%
CAMX
SEK 643.50
Camurus
7D
3.0%
1Y
17.9%
CESSA
DKK 12.40
Cessatech
7D
3.5%
1Y
-1.2%
ORX
SEK 28.05
Orexo
7D
-2.4%
1Y
184.8%

ORX: Future Profit Margin Gains And R&D Move To Support Outlook

Narrative Update on Orexo Analysts have maintained their fair value estimate for Orexo at $31.00, citing stable expectations for revenue growth and recent improvements in profit margin projections as key factors supporting their unchanged price target. What's in the News Orexo AB is relocating to modern premises in Uppsala Science Park to strengthen research and development, enhance collaboration, and promote sustainability within its operations (Key Developments).
IBT B
SEK 50.40
Infant Bacterial Therapeutics
7D
-18.4%
1Y
41.6%
CINPHA
SEK 17.60
Cinclus Pharma Holding
7D
-3.1%
1Y
-13.0%

CINPHA: Clear FDA Guidance Will Drive Late-Stage Trial Progress

Narrative Update on Cinclus Pharma Holding Analysts have maintained their price target for Cinclus Pharma Holding at SEK 55.00. They noted only minor updates to profit margin and discount rate projections, with no change to their fair value estimate.
SECARE
SEK 34.80
Swedencare
7D
0.7%
1Y
-22.2%
ONCOZ
SEK 6.37
OncoZenge
7D
20.2%
1Y
-38.4%
DICOT
SEK 0.41
Dicot Pharma
7D
-7.3%
1Y
82.6%
NEWBRY
SEK 1.54
Newbury Pharmaceuticals
7D
-21.6%
1Y
-58.2%
FLERIE
SEK 38.85
Flerie
7D
0.4%
1Y
-13.9%
ACUC
SEK 0.76
AcuCort
7D
2.0%
1Y
-9.9%
ERMA
SEK 2.85
Enorama Pharma
7D
9.2%
1Y
-27.1%
KLAR
SEK 0.46
Klaria Pharma Holding AB (publ.)
7D
-7.3%
1Y
4.8%